Cefixime

-
Therapeutic Class
3rd Generation Cephalosporin Antibiotic

Clinical Teaching

  • This drug may cause abdominal pain or nausea.
  • Instruct patient to report signs/symptoms serum-sickness-like reactions (rash, urticaria, arthralgia, fever, malaise, enlarged lymph nodes).
  • Advise patient to report severe diarrhea and consult healthcare professional prior to taking anti-diarrhea medicine. Other superinfection signs/symptoms should be reported as well.

Dosing - Adult
Acute infective exacerbation of chronic obstructive pulmonary disease: 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection
Bronchitis, acute: 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection
Gonorrhea: uncomplicated, 400 mg ORALLY as one-time dose
Gonorrhea: disseminated (after parenteral therapy), 400 mg ORALLY twice a day to complete at least one week of therapy
Otitis media: 400 mg ORALLY once a day or divided twice a day, depending on type and severity of infection
Pharyngitis: 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection
Tonsillitis: 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection
Urinary tract infectious disease, Uncomplicated: 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection

Dosing - Pediatric
Acute infective exacerbation of chronic obstructive pulmonary disease: (6 months to 12 years of age) 8 mg/kg/day ORALLY once a day or divided twice a day; depending on type and severity of infection
Acute infective exacerbation of chronic obstructive pulmonary disease: (over 50 kg or over 12 years of age) 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection
Bronchitis, acute: (6 months to 12 years of age) 8 mg/kg/day ORALLY once a day or divided twice a day; depending on type and severity of infection
Bronchitis, acute: (over 50 kg or over 12 years of age) 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection
Gonorrhea: uncomplicated (greater than 45 kg), 400 mg ORALLY as one-time dose
Otitis media: (6 months to 12 years of age) 8 mg/kg/day ORALLY once a day or divided twice a day; depending on type and severity of infection
Otitis media: (over 50 kg or over 12 years of age) 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection
Pharyngitis: (6 months to 12 years of age) 8 mg/kg/day ORALLY once a day or divided twice a day; depending on type and severity of infection
Pharyngitis: (over 50 kg or over 12 years of age) 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection
Tonsillitis: (6 months to 12 years of age) 8 mg/kg/day ORALLY once a day or divided twice a day; depending on type and severity of infection
Tonsillitis: (over 50 kg or over 12 years of age) 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection
Urinary tract infectious disease, Uncomplicated: (6 months to 12 years of age) 8 mg/kg/day ORALLY once a day or divided twice a day; depending on type and severity of infection
Urinary tract infectious disease, Uncomplicated: (over 50 kg or over 12 years of age) 400 mg ORALLY once a day or divided twice a day; depending on type and severity of infection.

Adverse Effects - Common
Dermatologic: Pruritus, Rash, Urticaria
Gastrointestinal: Abdominal pain, Diarrhea, Nausea
Mechanism of Action
Cefixime, a semisynthetic cephalosporin, is a broad-spectrum bactericidal agent that inhibits cell-wall synthesis and is highly stable in the presence of beta lactamases .
Mechanism of Action - Pharmacokinetics
3 h to 4 h but may range up to 9 h
Oral: time to peak concentration, 2 h to 6 h
Protein binding: approximately 65%
Renal: approximately 50% unchanged
Bioavailability: about 40% to 50%
Dialyzable: no (hemodialysis), no (peritoneal dialysis)
moderate renal impairment (creatinine clearance of 20 mL/min to 40 mL/min): prolonged to 6.4 h
Effect of food: increases maximal absorption by approximately 0.8 h
severe renal impairment (creatinine clearance of 5 mL/min to 20 mL/min): increases to 11.5 h

Toxicology - Clinical Effects
CEPHALOSPORINS: OVERDOSE: Acute ingestion of large doses of cephalosporins may result in nausea, vomiting, diarrhea, and abdominal pain. Seizures have developed after parenteral overdose. ADVERSE EFFECTS: COMMON: Hypersensitivity reactions, including anaphylaxis, may commonly occur with therapy; oral exposures are less likely to cause severe allergic reactions than parenteral exposures. Seizures have also been reported following therapeutic administration. Prolonged prothrombin times, thrombocytopenia, and coagulopathies associated with a qualitative platelet defect and aggregation abnormalities have been reported following IV cephalosporin therapy. Pseudocholelithiasis may follow intravenous administration of ceftriaxone. Several cases of fatal hemolytic reactions following intravenous ceftriaxone therapy have been reported in children with serious hematologic abnormalities.

Comments

Post a Comment

Popular posts from this blog

Treatment Guidelines for Malaria Contd...

-
Treatment regimens for uncomplicated malaria in adults _ Oral quinine sulphate 600 mg/8 h for 5e7 days plus doxycycline 200 mg daily (or clindamycin 450 mg/8 h for pregnant women) for 7 days _ Atovaquoneeproguanil (Malarone_): 4 ‘standard’ tablets daily for 3 days or _ Co-artem ((artemetherelumefantrine_): if weight > 35 kg, 4 tablets  then 4 tablets at 8, 24, 36, 48 and 60 h   Child Initial dose 10 mg/kg/base then 5 mg/kg  base 6e8 h later and on days 2 and 3   However, both of these newer regimens need to be taken for only 3 days. In contrast, quinine needs to be taken for 5e7 days and is often associated with ‘‘cinchonism’’ (nausea, deafness and ringing in the ears), which often results in poor adherence. Although international recommendations suggest that quinine should be  taken for 7 days in endemic areas, 2  UK experience suggests  that 5 days treatment is adequate for the vast majority of cases. Quinine should be combined with a second drug (doxycycline for adults or clindam
Read more

Acute migraine treatments

-
Acetaminophen and NSAIDS First of treatment for mild migraines Time to onset: 1-2 hours Duration of effect: 2-3 hours, decreases with increasing frequency of use Side effects: can lead to GI bleeding, liver and renal dysfunction. Ergotamine Derivatives Ergotamine are fungal derivatives that are potent vasoconstrictors. Used for severe migraines. Time to onset: 15 min to 2 hours depending on route. Duration of effect: 2-4 hours. Side effects: increased BP, MI, stroke. Triptans Triptans are 5HT1B, 5HT1D agonists. Sumatriptan was the first to be introduced in 1991. Sumatriptan is used for severe migraine with 10 min time to onset and 60-70% efficacy with a duration of 2 hours. 2ndgeneration triptans have since been developed with increased efficacy and duration of action. Side effects are referred to as triptan sensations and include tingling, numbing, anxiety, heaviness or tightness in the chest and throat, and sensations of warmth, burning, cold, or pressure. Prophylaxis Treatment Beta
Read more

EFFECT OF ACETAMINOPHEN ON BLOOD PRESSURE

-
Acetaminophen produces its analgesic effect by inhibiting the same cyclooxygenase, prostaglandin H2 synthase, that is the target of NSAID and aspirin. However, acetaminophen blocks this enzyme at its peroxidase catalytic rather than at the cyclooxygenase catalytic site. Therefore, the acetaminophen-mediated inhibition is sensitive to changes in the tissue peroxide levels; higher concentrations of peroxide in activated leukocytes and platelets block the effect of acetaminophen on inflammation and platelet thrombosis. However, acetaminophen is able to inhibit prostaglandins in the central nervous system, thus providing relief of pain and fever. Therefore, acetaminophen is not an NSAID or anti-thrombotic agent.   Subscribe to Drugs Information Center by Email
Read more